Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds
April 27, 2023 at 09:15 AM EDT
Eli Lilly plans to complete its application for FDA approval of tirzepatide in the coming weeks and expects regulatory action as early as later this year.
